Interview with André Syrota, Director – General, INSERM –…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
Delpharm is a French Contract Manufacturing Organization with over 20 years history. The company generated revenues of EUR 380 million (USD 430 million) in 2015 and counts on a workforce of 2,500 across the ten manufacturing plants it owns. Delpharm’s core business is the production of pharmaceutical products for pharmaceutical companies, hence why productivity, responsiveness and flexibility are an on-going concern. Delpharm produces a wide range of forms from solids, pastes, and liquids to injectables and biotechnical-related products.
Contact
DELRIV
Port de Boulogne
In front of 9 quai du 4 Septembre
92100 Boulogne
France
Tel : +33 (0)1 41 09 19 70
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
Pharmaceuticals and Chemicals are inextricably linked industries which is evident through your board membership that is half comprised of chemical companies developing products for the pharmaceutical sector. To what degree…
France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been like? I have spent half…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the French model rewards innovative…
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market. Can you explain…
What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them? The main idea is that…
See our Cookie Privacy Policy Here
